The peripheral immune response and lung cancer prognosis

Attempts to refine and improve outcome predictions using tumor gene expression have been recently reported. We show that peripheral blood mononuclear cell (PBMC)-associated gene signatures can predict outcome in non- small cell lung carcinoma patients independent of demographic data or TNM staging, and that this information may persist after tumor resection.